AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
New Jersey Partners Merck, Schering Have Tough Quarter.
Byline: Lewis Krauskopf
Apr. 23--Two New Jersey drug makers in transition, with fortunes tied to the same franchise, reported mixed first-quarter results Thursday.
Merck & Co. reported that net income fell 5 percent, while Schering-Plough Corp. posted a $73 million loss. The companies share in the development and marketing of a cholesterol medicine, Vytorin, which officials reiterated Thursday was expected to launch in the third quarter.
"Obviously, all eyes are on the Vytorin approval and launch in the U.S.," said Girish Tyagi, an analyst with Thomas Weisel Partners.
Whitehouse Station-based Merck reported net income of $1.6 billion in the quarter. Last year's quarter included results from its Medco pharmacy benefits unit, which the company spun off in the fall. Without Medco, Merck said income from continuing operations rose nearly 5 percent. Earnings per share of 73 cents beat by a penny the consensus projection on Wall Street, according to Thomson First Call.
- Schering-Plough Healthcare Products to establish executive offices in New...
- Press release article from: PR Newswire November 2, 1989 700+ words
...be established in New Jersey for Schering-Plough HealthCare...Memphis will relocate to New Jersey. An additional 50 Schering-Plough employees...Plough/ (SGP) CO: Schering-Plough Corporation ST: New Jersey, Tennessee IN: HOU...
- Head of Schering-Plough Research Institute Named to New Jersey High-Tech Hall...
- Press release article from: PR Newswire April 5, 2005 700+ words
...senior vice president, Schering-Plough Corporation , and president, Schering-Plough Research Institute...HealthCare Institute of New Jersey (HINJ) as its pharmaceutical...Biotechnology Council of New Jersey; and AeA, Advancing...A member of the Schering-Plough Executive ...
- Schering-Plough Probe Wraps Up; New Jersey Drug Maker Won't Face Penalties.
- Newspaper article from: Knight Ridder/Tribune Business News October 2, 2003 700+ words
...a pill for hepatitis C. Schering-Plough operates two plants...and in Las Piedras. Some of Schering-Plough's more lucrative...The other two plants were in New Jersey, in Kenilworth and Union...with the FDA which requires Schering-Plough to comply with an...
- Schering-Plough Says U.S. Attorney's Office in New Jersey Closes Previously...
- Press release article from: PR Newswire October 1, 2003 700+ words
Schering-Plough Corporation today...Attorney's Office in New Jersey informed the company that...all documents submitted by Schering-Plough in connection with...returned to the company. Schering-Plough first reported...
- NEW JERSEY ENTERS MULTI-STATE SETTLEMENT WITH MERCK, SCHERING-PLOUGH, JOINT...
- News wire article from: US Fed News Service, Including US State News July 15, 2009 700+ words
...July 15 -- The New Jersey Attorney General...announced today that New Jersey has entered into...amp; Co. Inc, Schering-Plough Corporation...amp; Co., Schering-Plough and MSP...investigation. New Jersey, as part of the...
- US pharma concern Schering-Plough is building a pharmaceutical sciences centre...
- Magazine article from: Chemistry and Industry Eisberg, Neil August 27, 2007 700+ words
US pharma concern Schering-Plough is building a pharmaceutical sciences centre and office campus at Summit, New Jersey, for Schering-Plough Research Institute, its R&D arm, including...
- NJ to be US home for Bayer Schering Pharma, with 800 job cuts expected in the...
- Newspaper article from: Pharma Marketletter November 20, 2006 700+ words
...of fellow German drugmaker Schering AG (and its US subsidiary...200 later, and said that New Jersey would become home to its US...headquarters locations in New Jersey. Wayne and Montville, New Jersey will be headquarters for the...
- Dutch antibody specialist PanGenetics (Utrecht) has licensed an undisclosed...
- Magazine article from: Chemistry and Industry December 18, 2006 700+ words
...antibody from US pharma company Schering-Plough (Kenoilworth, New Jersey). After PanGenetics initial...and efficacy evaluations, Schering-Plough has the option to...license a second antibody from Schering-Plough, which becomes a...